Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DateTimeSourceHeadlineSymbolCompany
05/15/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:51PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/13/20243:30PMGlobeNewswire Inc.Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
04/24/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at Planet MicroCap ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
04/01/20243:15PMGlobeNewswire Inc.Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/28/20248:32AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/25/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/21/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/20/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/19/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/12/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at BIO-Europe SpringNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/11/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/11/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/07/20248:37AMGlobeNewswire Inc.New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/07/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/07/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of TherapyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/06/20244:01PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/06/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/06/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/05/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/05/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in HumansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/29/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/29/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/29/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/29/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/29/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/28/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
02/28/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy VolunteersNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Your Recent History

Delayed Upgrade Clock